Lymphocyte Predominant Hodgkin Lymphoma. A Multicenter Retrospective 30-Year Experience of the Italian Pediatric Hematology and Oncology Association (AIEOP)
M Mascarin, C Elia, M Bianchi, P Bertolini, S Buffardi, M Caniglia, R Caruso, M Cellini, S Cesaro, C Consarino, S D'Amico, R De Santis, P Farruggia, V Cecinati, A Garaventa, P Indolfi, ML Moleti, G Murgia, M Nardi, P Pierani, F Porta, R Rondelli, A Sala, N Sa… · Klinische Pädiatrie · 2014 · Heft 03
Bibliografische Angaben
Zusammenfassung
Question: Lymphocyte predominant Hodgkin lymphoma (LPHL) is an uncommon CD20+ entity, generally with an indolent course, representing ≈5% of Hodgkin Lymphoma (HL). The AIEOP carried out a multicenter retrospective study on LPHL patients (pts) to evaluate the overall survival (OS) and event free survival (EFS). Methods: We collected data and compare therapeutic results of pts diagnosed in 1983 – 2013. All evaluations were performed on 187 pts extract from 1773 HL (10.5%). The 187 pts were so parted: MH'83: 31/212 (14.6%), MH'89: 28/259 (10.8%), MH'96: 57/562 (10.1%), LH2004: 71/740 (9.6%). One pt was lost to foll…